由于担心产品可能被致癌化学物质污染,强生公司(Johnson & Johnson)主动从市场上召回了部分防晒喷雾产品。
7月14日,强生在一份声明中称,在检测出部分样品中含有较低的苯含量后,该公司将召回露得清(Neutrogena)和艾维诺(Aveeno)旗下的五款防晒喷雾产品。
强生表示,消费者应当立即停止使用受影响的产品,并作适当的丢弃处理。该公司指出,如果消费者在使用这些产品时产生了任何问题,或者担忧过、经历过任何问题,应该联系医生或医疗保健提供商。
苯被归类为人类致癌物,这意味着其有致癌风险,取决于人们接触这种化学物质的剂量和时间。致癌物可以通过皮肤不同程度地被吸收、吸入或口服。今年第一季度,强生的皮肤、健康和美容部门收入为12亿美元。截至2020年,其业务规模达到了45亿美元,业务囊括从防晒霜到痤疮和湿疹治疗等等。
强生认为,“日常接触这些气溶胶防晒产品中的苯(以我们检测到的水平而言)不会对健康造成不良后果。”尽管如此,该公司仍然表示,出于谨慎考虑,将召回这些产品。
强生召回的露得清防晒喷雾产品包括Beach Defense、Cool Dry Sport、Invisible Daily以及Ultra Sheer,而这些产品又有着不同的尺寸和防晒成分——露得清官网上公布的清单长达23页;被召回的艾维诺防晒喷雾名为Protect + Refresh。
今年5月,位于康涅狄格州纽黑文市的独立测试实验室——Valisure发现部分被广泛销售和使用的防晒霜和晒后护理产品的苯含量高达百万分之六。实验室向美国食品与药品管理局(Food and Drug Administration)提交了一份要求召回这些产品的请愿书。在Valisure发现的苯含量最高的防晒霜中,露得清名列榜首。
“当整个行业意识到这一问题后,我们立即开始对制造工艺和原材料进行全面的、端到端的调查,包括内部测试和详尽的数据审查。”强生的发言人杰克•萨金特说道。
Valisure还在CVS药房和其他许多品牌的防晒霜、晒后护理产品中检测到苯,但它确实也发现了不含苯的防晒霜。CVS没有立即回应置评请求。
“我们希望监管机构和厂商继续对涉及严重苯污染问题的防晒霜和其他产品采取进一步行动,让消费者无需担心面临不必要的风险。”Valisure的首席执行官大卫•莱特说。
莱特还称,在对强生产品的测试中,相比乳液类产品,为什么偏偏在喷雾剂类产品中检测出了苯尚不清楚,“但似乎这些喷雾类产品中很多都添加了大量酒精。”Valisure之前表示,当它们在一些洗手液中发现苯时,污染物可能是在净化酒精(主要起杀菌作用)的过程中引入的。
1977年的研究
1977年,一项具有里程碑意义的研究强调了苯的健康风险。之后,雇主和制造商在生产中被严格要求控制苯的含量。然而,最近几个月,在一些洗手液中却检测到苯的含量升高了。
目前,美国食品与药品管理局对防晒霜中苯含量的标准要求尚不明晰,但它在早些时候设定了一个与新冠疫情相关的临时规定,即洗手液中苯的含量要控制在百万分之二。
美国食品与药品管理局的发言人杰里米•卡恩表示,在收到Valisure的请愿书后,该机构就开始对防晒霜取样,并展开独立的调查分析。
“如果美国食品与药品管理局的测试发现任何安全问题,那么我们将与厂商合作,共同解决这些问题。”他说。“在这起事件中,我们将按此流程进行。”
强生旗下的消费者健康、制药和医疗设备等一系列产品一直问题频发。这家总部位于新泽西州新布伦什维克的公司已经因为婴儿爽身粉、人工髋关节、阴道网片和阿片类止痛药物等问题产品给人们造成的伤害而官司缠身,在法庭内外面临数十亿美元的索赔和调解费用。自2015 年以来,强生就未能在美国销售阿片类药物。
最近,强生在推出新冠疫苗时又遇到了挫折,该疫苗曾经一度被寄希望可以成为美国免疫运动的关键。然而美国食品与药品管理局已告知医疗卫生机构,该疫苗可能和两种非常罕见的副作用相关——格林-巴利综合征(Guillain-Barré Syndrome)和一种血小板减少引发的血栓。但美国的监管机构依然表示,接种疫苗的好处要远远超过未接种的风险。(财富中文网)
编译:杨二一、陈聪聪
由于担心产品可能被致癌化学物质污染,强生公司(Johnson & Johnson)主动从市场上召回了部分防晒喷雾产品。
7月14日,强生在一份声明中称,在检测出部分样品中含有较低的苯含量后,该公司将召回露得清(Neutrogena)和艾维诺(Aveeno)旗下的五款防晒喷雾产品。
强生表示,消费者应当立即停止使用受影响的产品,并作适当的丢弃处理。该公司指出,如果消费者在使用这些产品时产生了任何问题,或者担忧过、经历过任何问题,应该联系医生或医疗保健提供商。
苯被归类为人类致癌物,这意味着其有致癌风险,取决于人们接触这种化学物质的剂量和时间。致癌物可以通过皮肤不同程度地被吸收、吸入或口服。今年第一季度,强生的皮肤、健康和美容部门收入为12亿美元。截至2020年,其业务规模达到了45亿美元,业务囊括从防晒霜到痤疮和湿疹治疗等等。
强生认为,“日常接触这些气溶胶防晒产品中的苯(以我们检测到的水平而言)不会对健康造成不良后果。”尽管如此,该公司仍然表示,出于谨慎考虑,将召回这些产品。
强生召回的露得清防晒喷雾产品包括Beach Defense、Cool Dry Sport、Invisible Daily以及Ultra Sheer,而这些产品又有着不同的尺寸和防晒成分——露得清官网上公布的清单长达23页;被召回的艾维诺防晒喷雾名为Protect + Refresh。
今年5月,位于康涅狄格州纽黑文市的独立测试实验室——Valisure发现部分被广泛销售和使用的防晒霜和晒后护理产品的苯含量高达百万分之六。实验室向美国食品与药品管理局(Food and Drug Administration)提交了一份要求召回这些产品的请愿书。在Valisure发现的苯含量最高的防晒霜中,露得清名列榜首。
“当整个行业意识到这一问题后,我们立即开始对制造工艺和原材料进行全面的、端到端的调查,包括内部测试和详尽的数据审查。”强生的发言人杰克•萨金特说道。
Valisure还在CVS药房和其他许多品牌的防晒霜、晒后护理产品中检测到苯,但它确实也发现了不含苯的防晒霜。CVS没有立即回应置评请求。
“我们希望监管机构和厂商继续对涉及严重苯污染问题的防晒霜和其他产品采取进一步行动,让消费者无需担心面临不必要的风险。”Valisure的首席执行官大卫•莱特说。
莱特还称,在对强生产品的测试中,相比乳液类产品,为什么偏偏在喷雾剂类产品中检测出了苯尚不清楚,“但似乎这些喷雾类产品中很多都添加了大量酒精。”Valisure之前表示,当它们在一些洗手液中发现苯时,污染物可能是在净化酒精(主要起杀菌作用)的过程中引入的。
1977年的研究
1977年,一项具有里程碑意义的研究强调了苯的健康风险。之后,雇主和制造商在生产中被严格要求控制苯的含量。然而,最近几个月,在一些洗手液中却检测到苯的含量升高了。
目前,美国食品与药品管理局对防晒霜中苯含量的标准要求尚不明晰,但它在早些时候设定了一个与新冠疫情相关的临时规定,即洗手液中苯的含量要控制在百万分之二。
美国食品与药品管理局的发言人杰里米•卡恩表示,在收到Valisure的请愿书后,该机构就开始对防晒霜取样,并展开独立的调查分析。
“如果美国食品与药品管理局的测试发现任何安全问题,那么我们将与厂商合作,共同解决这些问题。”他说。“在这起事件中,我们将按此流程进行。”
强生旗下的消费者健康、制药和医疗设备等一系列产品一直问题频发。这家总部位于新泽西州新布伦什维克的公司已经因为婴儿爽身粉、人工髋关节、阴道网片和阿片类止痛药物等问题产品给人们造成的伤害而官司缠身,在法庭内外面临数十亿美元的索赔和调解费用。自2015 年以来,强生就未能在美国销售阿片类药物。
最近,强生在推出新冠疫苗时又遇到了挫折,该疫苗曾经一度被寄希望可以成为美国免疫运动的关键。然而美国食品与药品管理局已告知医疗卫生机构,该疫苗可能和两种非常罕见的副作用相关——格林-巴利综合征(Guillain-Barré Syndrome)和一种血小板减少引发的血栓。但美国的监管机构依然表示,接种疫苗的好处要远远超过未接种的风险。(财富中文网)
编译:杨二一、陈聪聪
Johnson & Johnson is voluntarily recalling some spray aerosol sunscreen from the market amid concerns that the products could be contaminated with a cancer-causing chemical.
The company said in a statement on July 14 that it is recalling all lots of five Neutrogena and Aveeno brand aerosol sunscreen product lines after testing identified low levels of benzene in some samples.
The company said consumers should stop using the affected products and appropriately discard them. Consumers should contact their physician or health-care provider if they have any questions, concerns or have experienced any problems related to using the products, J&J said.
Benzene is classified as a human carcinogen, meaning it is has the potential to cause cancer depending on how much of the chemical people are exposed to, and for how long. It can be absorbed to varying degrees through the skin, by inhalation or orally. In the first quarter, J&J’s skin, health and beauty unit drew $1.2 billion in revenue. In 2020, it was a $4.5 billion business, spanning from sunscreen to treatments for acne and eczema.
J&J said that “daily exposure to benzene in these aerosol sunscreen products at the levels detected in our testing would not be expected to cause adverse health consequences. Nonetheless, the company said it would recall the products out of an abundance of caution.
The recalled aerosol sunscreens under J&J’s Neutrogena brand include Beach Defense, Cool Dry Sport, Invisible Daily and Ultra Sheer. The products come in many different sizes and sun protection factors -- the list posted on Neutrogena’s website is 23 pages long. The Aveeno aerosol being recalled is called Protect + Refresh.
Valisure, an independent testing lab in New Haven, Connecticut, said in May it found some widely used sunscreens and after-sun products contained up to 6 parts per million of benzene. The company filed a petition with the Food and Drug Administration asking for the products to be recalled. Neutrogena topped the list of sunscreens with the highest levels of benzene found by Valisure.
“When the industry was alerted to this matter, we immediately began a comprehensive end-to-end investigation of our manufacturing process and raw materials, including internal testing and a thorough data review,” said Jake Sargent, a spokesman for J&J.
Valisure also detected benzene in CVS sunscreens as well as after-sun care products, among many other sunscreen brands, though it did find sunscreens that didn’t contain benzene. CVS did not immediately return a request for comment.
“We hope regulators and manufacturers continue to take further action on sunscreens and other products affected by serious contamination issues so that consumers do not need to worry about exposure to unnecessary risk,” Valisure Chief Executive Officer David Light said.
Light said it’s not certain why sprays specifically contained benzene in J&J’s tests compared to lotion, “but many of these aerosol products appear to use significant amounts of alcohol.” Valisure said previously, when it found benzene in some hand sanitizers, that the contaminant may have been introduced when alcohol -- the germ killer that is their main ingredient -- is purified.
1977 study
After a landmark study in 1977 highlighted its health risks, employers and manufacturers were forced to limit benzene in their workplaces. In recent months, however, elevated levels of benzene have been detected in some hand sanitizers.
The FDA’s standard for benzene in sunscreen is unclear, but it earlier set a temporary limit related to the pandemic of 2 parts per million for hand sanitizers.
After the FDA received Valisure’s petition, it began a process of securing sunscreen samples and conducting independent analysis, said Jeremy Kahn, an agency spokesman.
“If the FDA’s testing raises any safety concerns, then the FDA will work with manufacturers to address these concerns,” he said. “We are going through that process in this case.”
J&J has been confronting issues across its portfolio of products spanning its consumer health, pharmaceutical and medical device units. The New Brunswick, New Jersey-based company has faced billions in court losses and settlements from damage claims involving baby powder, artificial hips, vaginal-mesh devices and opioid painkillers. J&J hasn’t marketed opioids in the U.S. since 2015.
More recently, J&J has faced setbacks in the rollout of its Covid-19 vaccine, which was once anticipated to be a linchpin of the U.S. immunization campaign. The FDA has informed health providers about links between the vaccine and two very rare side effects: Guillain-Barré Syndrome and a type of blood clot known as thrombosis with thrombocytopenia. U.S. regulators have continued to suggest the benefits of the vaccine well outweigh the risks of going unvaccinated.